https://m2.mtmt.hu/ hun 2026-09-20 19:40 JournalArticle 35425736 ADMIN_APPROVED true 0 false 2026-09-11T08:47:22.889+0000 2026-06-02T09:01:38.529+0000 2024-09-30T06:37:48.962+0000 true 10070381 Demecs Éva /api/admin/10070381 Admin Demecs Éva (BCE 4 admin) true 2026-08-10T14:23:45.862+0000 2026-08-10T14:23:45.862+0000 2026-06-02T09:01:38.846+0000 true 10003133 Boros Annamária /api/admin/10003133 Admin Boros Annamária (MTMT Központi admin) true 10003133 Admin 10003133 /api/admin/10003133 Boros Annamária (MTMT Központi admin) Boros Annamária true 10003133 true 2026-06-05T13:23:18.956+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Szabó, Ákos true true /api/journal/10010882 REVIEWED EUROPEAN JOURNAL OF HEALTH ECONOMICS 1618-7598 1618-7601 true false 10010882 false 10010882 true 1618-7598 1618-7601 Journal FOREIGN 26 4 627 639 627 13 2025 Funding 2045192 /api/funding/2045192 (Új Nemzeti Kiválóság Program (ÚNKP-22-3-II-SE-5)) false true Funding 2045193 /api/funding/2045193 (Bolyai János Kutatási Ösztöndíj (BO/00304/21)) Támogató: MTA Bolyai pályázat false true Funding 2045194 /api/funding/2045194 ÚNKP-23-5-CORVINUS-5(Új Nemzeti Kiválóság Program) false true true 2024 true true true false true false GREEN 2026-09-11 true http://unipub.lib.uni-corvinus.hu/10415 8 0 8 5 4 8 8 8 8 8 8 5 5 5 3 0 8 5 8 5 0 20 20 Folyóiratcikk Journal Article 24 8 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2025 0 4 4 4 4 2026 0 4 1 4 1 D1 B nemzetközi false false false false 2024-12-29T07:37:55.165+0000 Doktori Iskola (SE); Egészségpolitika Tanszék (BCE / TPTI) 3 21 2 3 0 true 10003133 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 120690740 /api/authorship/120690740 Szabó, Ákos [Szabó, Ákos (Számviteli szakem...), szerző] Doktori Iskola (SE); Egészségpolitika Tanszék (BCE / TPTI) 1 0.333 true false false Author 10075068 /api/author/10075068 Szabó Ákos (Számviteli szakemberek jóllétje és transzferárazás) Szabó Ákos true true Szabó Ákos true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 120690741 /api/authorship/120690741 Brodszky, Valentin [Brodszky, Valentin (health outcome re...), szerző] Egészségpolitika Tanszék (BCE / TPTI) 2 0.333 false false false Author 10020545 /api/author/10020545 Brodszky Valentin (health outcome research) Brodszky Valentin true 10020545 true Brodszky Valentin true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 120690742 /api/authorship/120690742 Rencz, Fanni ✉ [Rencz, Fanni (orvostudomány, he...), szerző] Egészségpolitika Tanszék (BCE / TPTI); Doktori Iskola (SE) 3 0.333 false true true Author 10048079 /api/author/10048079 Rencz Fanni (orvostudomány, health outcomes research) Rencz Fanni true 10048079 true Rencz Fanni true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 27560684 /api/publicationidentifier/27560684 DOI: 10.1007/s10198-024-01728-5 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1007/s10198-024-01728-5 https://doi.org/10.1007/s10198-024-01728-5 false true PublicationIdentifier 27560687 /api/publicationidentifier/27560687 CorvinusKutatasok: 10415 SwordSource 94 /api/publicationsource/94 CorvinusKutatasok PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true CorvinusKutatasok http://unipub.lib.uni-corvinus.hu/@@@ true true 94 true GREEN true IDENTICAL 10415 http://unipub.lib.uni-corvinus.hu/10415 false true PublicationIdentifier 27565479 /api/publicationidentifier/27565479 REAL: 206557 SwordSource 36 /api/publicationsource/36 REAL PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true REAL REAL https://real.mtak.hu/@@@ true true 36 true GREEN true IDENTICAL 206557 https://real.mtak.hu/206557 false true PublicationIdentifier 27617948 /api/publicationidentifier/27617948 WoS: 001320987700001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001320987700001 https://www.webofscience.com/wos/woscc/full-record/001320987700001 true true PublicationIdentifier 27599076 /api/publicationidentifier/27599076 Scopus: 85205246131 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85205246131 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85205246131 false true PublicationIdentifier 27599077 /api/publicationidentifier/27599077 PubMed: 39340749 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 39340749 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39340749&dopt=Abstract false true MtaRating 508499 /api/mtarating/508499 IX. Gazdaságtudományi Doktori Minősítő Bizottság:B nemzetközi EUROPEAN JOURNAL OF HEALTH ECONOMICS 1618-7598 1618-7601 RatingType 10012 /api/ratingtype/10012 IX. Gazdaságtudományi Doktori Minősítő Bizottság GMB Institute 19066 /api/institute/19066 Gazdaságtudományi Doktori Minősítő Bizottság IXGJO GMB [1901-] 0 false true false Gazdaságtudományi Doktori Minősítő Bizottság Committee on Economics true 19066 true true true B nemzetközi true 8499 true MtaRating 11507806 /api/mtarating/11507806 IX. Szociológiai Tudományos Bizottság:B nemzetközi EUROPEAN JOURNAL OF HEALTH ECONOMICS 1618-7598 1618-7601 RatingType 10007 /api/ratingtype/10007 IX. Szociológiai Tudományos Bizottság SZTB Institute 14102 /api/institute/14102 Szociológiai Tudományos Bizottság IXGJO SZTB [1901-] 0 false true false Szociológiai Tudományos Bizottság Committee on Sociology true 14102 true true true B nemzetközi false true SjrRating 11576475 /api/sjrrating/11576475 sjr:D1 (2025) Scopus - Economics, Econometrics and Finance (miscellaneous) EUROPEAN JOURNAL OF HEALTH ECONOMICS 1618-7598 1618-7601 41 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2001 /api/classificationexternal/2001 Scopus - Economics, Econometrics and Finance (miscellaneous) true 2001 true D1 DIRECT true true Reference 58271854 /api/reference/58271854 1. Ali, F., Vyas, J., Finlay, A.Y.: Counting the Burden: Atopic dermatitis and health-related quality of life. Acta dermato-venereologica. 100(12), adv00161 (2020). https://doi.org/10.2340/00015555-3511, DOI: 10.2340/00015555-3511 1 10.2340/00015555-3511 false true Reference 58271855 /api/reference/58271855 2. Eichenfield, D.Z., Sprague, J., Eichenfield, L.F.: Management of Acne Vulgaris: A review. Jama. 326(20), 2055–2067 (2021). https://doi.org/10.1001/jama.2021.17633, DOI: 10.1001/jama.2021.17633 2 10.1001/jama.2021.17633 false true Reference 58271856 /api/reference/58271856 3. Langley, R.G., Krueger, G.G., Griffiths, C.E.: Psoriasis: Epidemiology, clinical features, and quality of life. Ann. Rheum. Dis. 64(Suppl 2), ii18–23 (2005). https://doi.org/10.1136/ard.2004.033217, DOI: 10.1136/ard.2004.033217 3 10.1136/ard.2004.033217 false true Reference 58271857 /api/reference/58271857 4. Seth, D., Cheldize, K., Brown, D., Freeman, E.F.: Global burden of skin disease: Inequities and innovations. Curr. Dermatology Rep. 6(3), 204–210 (2017). https://doi.org/10.1007/s13671-017-0192-7, DOI: 10.1007/s13671-017-0192-7 4 10.1007/s13671-017-0192-7 false true Reference 58271858 /api/reference/58271858 5. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017: Lancet (London England). 392(10159), 1789–1858 (2018). https://doi.org/10.1016/s0140-6736(18)32279-7, DOI: 10.1016/s0140-6736(18)32279-7 5 10.1016/s0140-6736(18)32279-7 false true Reference 58271859 /api/reference/58271859 6. Kromer, C., Sonntag, C.D., Peitsch, D.: Biologicals and small molecules in psoriasis: A systematic review of economic evaluations. PloS One. 13(1), e0189765 (2018). https://doi.org/10.1371/journal.pone.0189765, DOI: 10.1371/journal.pone.0189765 6 10.1371/journal.pone.0189765 false true Reference 58271860 /api/reference/58271860 7. Brazier, J., Ratcliffe, J., Saloman, J., Tsuchiya, A.: Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press (2017), DOI: 10.1093/med/9780198725923.001.0001 7 10.1093/med/9780198725923.001.0001 false true Reference 58271861 /api/reference/58271861 8. Kaplan, R.M., Hays, R.D.: Health-Related Quality of Life Measurement in Public Health. Annu. Rev. Public Health. 43, 355–373 (2022). https://doi.org/10.1146/annurev-publhealth-052120-012811, DOI: 10.1146/annurev-publhealth-052120-012811 8 10.1146/annurev-publhealth-052120-012811 false true Reference 58271862 /api/reference/58271862 9. Torrance, G.W.: Utility approach to measuring health-related quality of life. J. Chronic Dis. 40(6), 593–603 (1987). https://doi.org/10.1016/0021-9681(87)90019-1, DOI: 10.1016/0021-9681(87)90019-1 9 10.1016/0021-9681(87)90019-1 false true Reference 58271863 /api/reference/58271863 10. Attema, A.E., Edelaar-Peeters, Y., Versteegh, M.M., Stolk, E.A.: Time trade-off: One methodology, different methods. Eur. J. Health Eco. 14(Suppl 1), S53–64 (2013). https://doi.org/10.1007/s10198-013-0508-x, DOI: 10.1007/s10198-013-0508-x 10 10.1007/s10198-013-0508-x false true Reference 58271864 /api/reference/58271864 11. Richardson, J., Iezzi, A., Khan, M.A.: Why do multi-attribute utility instruments produce different utilities: The relative importance of the descriptive systems, scale and ‘micro-utility’ effects. Qual. Life Res. 24(8), 2045–2053 (2015). https://doi.org/10.1007/s11136-015-0926-6, DOI: 10.1007/s11136-015-0926-6 11 10.1007/s11136-015-0926-6 false true Reference 58271865 /api/reference/58271865 12. Rowen, D., Azzabi Zouraq, I., Chevrou-Severac, H., van Hout, B.: International Regulations and Recommendations for Utility Data for Health Technology Assessment. PharmacoEconomics. 35(Suppl 1), 11–19 (2017). https://doi.org/10.1007/s40273-017-0544-y, DOI: 10.1007/s40273-017-0544-y 12 10.1007/s40273-017-0544-y false true Reference 58271866 /api/reference/58271866 13. Brazier, J., Ara, R., Rowen, D., Chevrou-Severac, H.: A review of generic preference-based measures for use in cost-effectiveness models. PharmacoEconomics. 35(Suppl 1), 21–31 (2017). https://doi.org/10.1007/s40273-017-0545-x, DOI: 10.1007/s40273-017-0545-x 13 10.1007/s40273-017-0545-x false true Reference 58271867 /api/reference/58271867 14. Heinz, K.C., Beaudart, C., Willems, D., Wiethoff, I., Hiligsmann, M.: Cost-effectiveness of emerging treatments for atopic dermatitis. Syst. Rev. PharmacoEconomics. 41(11), 1415–1435 (2023). https://doi.org/10.1007/s40273-023-01293-4, DOI: 10.1007/s40273-023-01293-4 14 10.1007/s40273-023-01293-4 false true Reference 58271868 /api/reference/58271868 15. Igarashi, A., Yuasa, A., Yonemoto, N., et al.: A Systematic Literature Review of Economic Evaluations and cost studies of the Treatment of Psoriasis, atopic dermatitis, and chronic Urticaria. Dermatology Therapy. 12(8), 1729–1751 (2022). https://doi.org/10.1007/s13555-022-00774-2, DOI: 10.1007/s13555-022-00774-2 15 10.1007/s13555-022-00774-2 false true Reference 58271869 /api/reference/58271869 16. Lieke, C.J., Nicole, W.J.K.-S., Andrea, P., Klara, M., Brigitte, A.B.E.: A systematic review of economic evaluations for the interventions of superficial basal cell carcinoma. EJC Skin. Cancer. 1, 100008 (2023). https://doi.org/10.1016/j.ejcskn.2023.100008, DOI: 10.1016/j.ejcskn.2023.100008 16 10.1016/j.ejcskn.2023.100008 false true Reference 58271870 /api/reference/58271870 17. Chen, S.C., Bayoumi, A.M., Soon, S.L., et al.: A catalog of dermatology utilities: A measure of the burden of skin diseases. J. Invest. Dermatology Symp. Proc. 9(2), 160–168 (2004). https://doi.org/10.1046/j.1087-0024.2003.09112.x, DOI: 10.1046/j.1087-0024.2003.09112.x 17 10.1046/j.1087-0024.2003.09112.x false true Reference 58271871 /api/reference/58271871 18. Yang, Y., Brazier, J., Longworth, L.: EQ-5D in skin conditions: An assessment of validity and responsiveness. Eur. J. Health Economics. 16(9), 927–939 (2015). https://doi.org/10.1007/s10198-014-0638-9, DOI: 10.1007/s10198-014-0638-9 18 10.1007/s10198-014-0638-9 false true Reference 58271872 /api/reference/58271872 19. Ruzsa, G., Rencz, F., Brodszky, V.: Assessment of health state utilities in dermatology: An experimental time trade-off value set for the dermatology life quality index. Health Qual. Life Outcomes. 20(1), 87 (2022). https://doi.org/10.1186/s12955-022-01995-x, DOI: 10.1186/s12955-022-01995-x 19 10.1186/s12955-022-01995-x false true Reference 58271873 /api/reference/58271873 20. Blome, C., Beikert, F.C., Rustenbach, S.J., Augustin, M.: Mapping DLQI on EQ-5D in psoriasis: Transformation of skin-specific health-related quality of life into utilities. Arch. Dermatol. Res. 305(3), 197–204 (2013). https://doi.org/10.1007/s00403-012-1309-2, DOI: 10.1007/s00403-012-1309-2 20 10.1007/s00403-012-1309-2 false true Reference 58271874 /api/reference/58271874 21. Davison, N.J., Thompson, A.J., Turner, A.J., et al.: Generating EQ-5D-3L utility scores from the Dermatology Life Quality Index: A mapping study in patients with psoriasis. Value Health. 21(8), 1010–1018 (2018). https://doi.org/10.1016/j.jval.2017.10.024, DOI: 10.1016/j.jval.2017.10.024 21 10.1016/j.jval.2017.10.024 false true Reference 58271875 /api/reference/58271875 22. Herédi, E., Rencz, F., Balogh, O., et al.: Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: A cross-sectional study in psoriasis from Hungary. Eur J Health Econ. 15(Suppl 1), S111–S119 (2014). https://doi.org/10.1007/s10198-014-0600-x, DOI: 10.1007/s10198-014-0600-x 22 10.1007/s10198-014-0600-x false true Reference 58271876 /api/reference/58271876 23. Vilsbøll, A.W., Kragh, N., Hahn-Pedersen, J., Jensen, C.E.: Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study. Quality of Life Research. 29(9), 2529–2539 (2020). https://doi.org/10.1007/s11136-020-02499-1, DOI: 10.1007/s11136-020-02499-1 23 10.1007/s11136-020-02499-1 false true Reference 58271877 /api/reference/58271877 24. Balp, M.M., Khalil, S., Tian, H., Gabriel, S., Vietri, J., Zuberbier, T.: Burden of chronic urticaria relative to psoriasis in five European countries. J. Eur. Acad. Dermatology Venereology 32(2), 282–290 (2018). https://doi.org/10.1111/jdv.14584, DOI: 10.1111/jdv.14584 24 10.1111/jdv.14584 false true Reference 58271878 /api/reference/58271878 25. Hirvonen, M.J., Pasternack, R., Lipitsä, T., et al.: Patients with Hidradenitis Suppurativa Suffer from Low Health-Related Quality of Life as measured by the generic 15D instrument. Skin appendage disorders. 8(3):221–227. (2022). https://doi.org/10.1159/000520839, DOI: 10.1159/000520839 25 10.1159/000520839 false true Reference 58271879 /api/reference/58271879 26. Silverberg, J.I., Margolis, D.J., Boguniewicz, M., et al.: Validation of five patient-reported outcomes for atopic dermatitis severity in adults. Br. J. Dermatol. 182(1), 104–111 (2020). https://doi.org/10.1111/bjd.18002, DOI: 10.1111/bjd.18002 26 10.1111/bjd.18002 false true Reference 58271880 /api/reference/58271880 27. Rencz, F., Brodszky, V., Janssen, M.F.: A direct comparison of the Measurement properties of EQ-5D-5L, PROMIS-29+2 and PROMIS Global Health Instruments and EQ-5D-5L and PROPr utilities in a General Population Sample. Value Health. 26(7), 1045–1056 (2023). https://doi.org/10.1016/j.jval.2023.02.002, DOI: 10.1016/j.jval.2023.02.002 27 10.1016/j.jval.2023.02.002 false true Reference 58271881 /api/reference/58271881 28. Zhang, J., Dewitt, B., Tang, E., et al.: Evaluation of PROMIS Preference Scoring System (PROPr) in patients undergoing hemodialysis or kidney transplant. Clin. J. Am. Soc. Nephrology: 16(9), 1328–1336 (2021). https://doi.org/10.2215/cjn.01880221, DOI: 10.2215/cjn.01880221 28 10.2215/cjn.01880221 false true Reference 58271882 /api/reference/58271882 29. Ahmad, H., Campbell, J.A., van der Mei, I., et al.: Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: Implications for health economic evaluation models. Quality of Life Research. 32(12), 3373–3387 (2023). https://doi.org/10.1007/s11136-023-03486-y, DOI: 10.1007/s11136-023-03486-y 29 10.1007/s11136-023-03486-y false true Reference 58271883 /api/reference/58271883 30. Pan, T., Wu, Y., Buchanan, J., Goranitis, I.: QALYs and rare diseases: Exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia. Health Qual. Life Outcomes. 21(1), 132 (2023). https://doi.org/10.1186/s12955-023-02216-9, DOI: 10.1186/s12955-023-02216-9 30 10.1186/s12955-023-02216-9 false true Reference 58271884 /api/reference/58271884 31. Richardson, J., Khan, M.A., Iezzi, A., Maxwell, A.: Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments. Med. Decis. Making. 35(3), 276–291 (2015). https://doi.org/10.1177/0272989x14543107, DOI: 10.1177/0272989x14543107 31 10.1177/0272989x14543107 false true Reference 58271885 /api/reference/58271885 32. Bató, A., Brodszky, V., Gergely, L.H., et al.: The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa. Qual. Life Res. 30(5):1477–1490. (2021). https://doi.org/10.1007/s11136-020-02732-x, DOI: 10.1007/s11136-020-02732-x 32 10.1007/s11136-020-02732-x false true Reference 58271886 /api/reference/58271886 33. Koszorú, K., Hajdu, K., Brodszky, V., et al.: Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis. Eur. J. Health Eco. 24(1), 139–152 (2023). https://doi.org/10.1007/s10198-022-01460-y, DOI: 10.1007/s10198-022-01460-y 33 10.1007/s10198-022-01460-y false true Reference 58271887 /api/reference/58271887 34. Poór, A.K., Rencz, F., Brodszky, V., et al.: Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Qual. Life Res. 26(12), 3409–3419 (2017). https://doi.org/10.1007/s11136-017-1699-x, DOI: 10.1007/s11136-017-1699-x 34 10.1007/s11136-017-1699-x false true Reference 58271888 /api/reference/58271888 35. Rencz, F., Janssen, M.F.: Analyzing the Pain/Discomfort and Anxiety/Depression composite domains and the meaning of discomfort in the EQ-5D: A mixed-methods study. Value Health. 25(12), 2003–2016 (2022). https://doi.org/10.1016/j.jval.2022.06.012, DOI: 10.1016/j.jval.2022.06.012 35 10.1016/j.jval.2022.06.012 false true Reference 58271889 /api/reference/58271889 36. Bató, A., Brodszky, V., Mitev, A.Z., Jenei, B., Rencz, F.: Psychometric properties and general population reference values for PROMIS Global Health in Hungary. Eur. J. Health Eco. (2023). https://doi.org/10.1007/s10198-023-01610-w, DOI: 10.1007/s10198-023-01610-w 36 10.1007/s10198-023-01610-w false true Reference 58271890 /api/reference/58271890 37. Jenei, B., Bató, A., Mitev, A.Z., Brodszky, V., Rencz, F.: Hungarian PROMIS-29+2: Psychometric properties and population reference values. Qual. Life Res. 32(8), 2179–2194 (2023). https://doi.org/10.1007/s11136-023-03364-7, DOI: 10.1007/s11136-023-03364-7 37 10.1007/s11136-023-03364-7 false true Reference 58271891 /api/reference/58271891 38. Nikl, A., Janssen, M.F., Jenei, B., Brodszky, V., Rencz, F.: Population norms for the EQ-5D-5L, PROPr and SF-6D in Hungary. PharmacoEconomics. 42(5), 583–603 (2024), DOI: 10.1007/s40273-024-01360-4 38 10.1007/s40273-024-01360-4 false true Reference 58271892 /api/reference/58271892 39. EUROSTAT: European Health Interview Survey (EHIS wave 3) — Methodological manual. 10.2785/020714. Accessed June 11:. (2018) (2021). https://doi.org/10.2785/020714, DOI: 10.2785/020714 39 10.2785/020714 false true Reference 58271893 /api/reference/58271893 40. Angyal, M.M., Lakatos, P.L., Jenei, B., Brodszky, V., Rencz, F.: Health utilities and willingness to pay in adult patients with coeliac disease in Hungary. Qual. Life Res. 32(9), 2503–2516 (2023). https://doi.org/10.1007/s11136-023-03418-w, DOI: 10.1007/s11136-023-03418-w 40 10.1007/s11136-023-03418-w false true Reference 58271894 /api/reference/58271894 41. Oppe, M., Devlin, N.J., van Hout, B., Krabbe, P.F., de Charro, F.: A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 17(4), 445–453 (2014). https://doi.org/10.1016/j.jval.2014.04.002, DOI: 10.1016/j.jval.2014.04.002 41 10.1016/j.jval.2014.04.002 false true Reference 58271895 /api/reference/58271895 42. Rencz, F., Brodszky, V., Gulácsi, L., et al.: Parallel valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary. Value Health. 23(9), 1235–1245 (2020). https://doi.org/10.1016/j.jval.2020.03.019, DOI: 10.1016/j.jval.2020.03.019 42 10.1016/j.jval.2020.03.019 false true Reference 58271896 /api/reference/58271896 43. Rencz, F., Péntek, M., Stalmeier, P.F.M., et al.: Bleeding out the quality-adjusted life years: Evaluating the burden of primary dysmenorrhea using time trade-off and willingness-to-pay methods. Pain. 158(11), 2259–2267 (2017). https://doi.org/10.1097/j.pain.0000000000001028, DOI: 10.1097/j.pain.0000000000001028 43 10.1097/j.pain.0000000000001028 false true Reference 58271897 /api/reference/58271897 44. Rencz, F., Ruzsa, G., Bató, A., Yang, Z., Finch, A.P., Brodszky, V.: Value Set for the EQ-5D-Y-3L in Hungary. PharmacoEconomics. 40(Suppl 2), 205–215 (2022). https://doi.org/10.1007/s40273-022-01190-2, DOI: 10.1007/s40273-022-01190-2 44 10.1007/s40273-022-01190-2 false true Reference 58271898 /api/reference/58271898 45. Herdman, M., Gudex, C., Lloyd, A., et al.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research. 20(10), 1727–1736 (2011). https://doi.org/10.1007/s11136-011-9903-x, DOI: 10.1007/s11136-011-9903-x 45 10.1007/s11136-011-9903-x false true Reference 58271899 /api/reference/58271899 46. Pickard, A.S., Law, E.H., Jiang, R., et al.: United States Valuation of EQ-5D-5L Health States using an International Protocol. Value Health. 22(8), 931–941 (2019). https://doi.org/10.1016/j.jval.2019.02.009, DOI: 10.1016/j.jval.2019.02.009 46 10.1016/j.jval.2019.02.009 false true Reference 58271900 /api/reference/58271900 47. Cella, D., Choi, S.W., Condon, D.M., et al.: PROMIS(®) Adult Health profiles: Efficient short-form measures of Seven Health domains. Value Health. 22(5), 537–544 (2019). https://doi.org/10.1016/j.jval.2019.02.004, DOI: 10.1016/j.jval.2019.02.004 47 10.1016/j.jval.2019.02.004 false true Reference 58271901 /api/reference/58271901 48. Dewitt, B., Feeny, D., Fischhoff, B., et al.: Estimation of a preference-based Summary score for the patient-reported outcomes Measurement Information System: The PROMIS(®)-Preference (PROPr) Scoring System. Med. Decis. Making. 38(6), 683–698 (2018). https://doi.org/10.1177/0272989x18776637, DOI: 10.1177/0272989x18776637 48 10.1177/0272989x18776637 false true Reference 58271902 /api/reference/58271902 49. Ware, J.E. Jr., Sherbourne, C.D.: The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med. Care. 30(6), 473–483 (1992), DOI: 10.1097/00005650-199206000-00002 49 10.1097/00005650-199206000-00002 false true Reference 58271903 /api/reference/58271903 50. Craig, B.M., Pickard, A.S., Stolk, E., Brazier, J.E.: US valuation of the SF-6D. Med. Decis. Making. 33(6), 793–803 (2013). https://doi.org/10.1177/0272989x13482524, DOI: 10.1177/0272989x13482524 50 10.1177/0272989x13482524 false true Reference 58271904 /api/reference/58271904 51. Hays, R.D., Bjorner, J.B., Revicki, D.A., Spritzer, K.L., Cella, D.: Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual. Life Res. 18(7), 873–880 (2009). https://doi.org/10.1007/s11136-009-9496-9, DOI: 10.1007/s11136-009-9496-9 51 10.1007/s11136-009-9496-9 false true Reference 58271905 /api/reference/58271905 52. Terwee, C.B., Bot, S.D., de Boer, M.R., et al.: Quality criteria were proposed for measurement properties of health status questionnaires. J. Clin. Epidemiol. 60(1), 34–42 (2007). https://doi.org/10.1016/j.jclinepi.2006.03.012, DOI: 10.1016/j.jclinepi.2006.03.012 52 10.1016/j.jclinepi.2006.03.012 false true Reference 58271906 /api/reference/58271906 53. Feng, Y.S., Kohlmann, T., Janssen, M.F., Buchholz, I.: Psychometric properties of the EQ-5D-5L: A systematic review of the literature. Quality of Life Research. 30(3), 647–673 (2021). https://doi.org/10.1007/s11136-020-02688-y, DOI: 10.1007/s11136-020-02688-y 53 10.1007/s11136-020-02688-y false true Reference 58271907 /api/reference/58271907 54. Evans, J.D.: Straightforward Statistics for the Behavioral Sciences. Thomson Brooks/Cole Publishing Co (1996) 54 false true Reference 58271908 /api/reference/58271908 55. Klapproth, C.P., Sidey-Gibbons, C.J., Valderas, J.M., Rose, M., Fischer, F.: Comparison of the PROMIS Preference score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany. Value Health. 25(5), 824–834 (2022). https://doi.org/10.1016/j.jval.2021.10.012, DOI: 10.1016/j.jval.2021.10.012 55 10.1016/j.jval.2021.10.012 false true Reference 58271909 /api/reference/58271909 56. Pan, T., Mulhern, B., Viney, R., Norman, R., Hanmer, J., Devlin, N.: A comparison of PROPr and EQ-5D-5L value sets. PharmacoEconomics. 40(3), 297–307 (2022). https://doi.org/10.1007/s40273-021-01109-3, DOI: 10.1007/s40273-021-01109-3 56 10.1007/s40273-021-01109-3 false true Reference 58271910 /api/reference/58271910 57. Sayah, F.A., Qiu, W., Xie, F., Johnson, J.A.: Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Quality of Life Research. 26(8), 2057–2066 (2017). https://doi.org/10.1007/s11136-017-1559-8, DOI: 10.1007/s11136-017-1559-8 57 10.1007/s11136-017-1559-8 false true Reference 58271911 /api/reference/58271911 58. Xu, R.H., Ma, B., Xin, H., et al.: Measurement properties of the EQ-5D-5L and PROPr in patients with spinal muscular atrophy. Health Qual. Life Outcomes. 21(1), 123 (2023). https://doi.org/10.1186/s12955-023-02204-z, DOI: 10.1186/s12955-023-02204-z 58 10.1186/s12955-023-02204-z false true Reference 58271912 /api/reference/58271912 59. Mulhern, B.J., Pan, T., Norman, R., et al.: U measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr. Quality of Life Research. 32(11), 3147–3160. (2023) https://doi.org/10.1007/s11136-023-03462-6, DOI: 10.1007/s11136-023-03462-6 59 10.1007/s11136-023-03462-6 false true Reference 58271913 /api/reference/58271913 60. Brazier, J., Roberts, J., Tsuchiya, A., Busschbach, J.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13(9), 873–884 (2004). https://doi.org/10.1002/hec.866, DOI: 10.1002/hec.866 60 10.1002/hec.866 false true Reference 58271914 /api/reference/58271914 61. Cicchetti, D.V.: Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol. Assess. 6(4), 284–290 (1994). https://doi.org/10.1037/1040-3590.6.4.284, DOI: 10.1037/1040-3590.6.4.284 61 10.1037/1040-3590.6.4.284 false true Reference 58271915 /api/reference/58271915 62. Shrout, P.E., Fleiss, J.L.: Intraclass correlations: Uses in assessing rater reliability. Psychol. Bull. 86(2), 420–428 (1979). https://doi.org/10.1037//0033-2909.86.2.420, DOI: 10.1037//0033-2909.86.2.420 62 10.1037//0033-2909.86.2.420 false true Reference 58271916 /api/reference/58271916 63. Bland, J.M., Altman, D.G.: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (London England). 1(8476), 307–310 (1986), DOI: 10.1016/S0140-6736(86)90837-8 63 10.1016/S0140-6736(86)90837-8 false true Reference 58271917 /api/reference/58271917 64. Giavarina, D.: Understanding bland altman analysis. Biochemia Med. 25(2), 141–151 (2015), DOI: 10.11613/BM.2015.015 64 10.11613/BM.2015.015 false true Reference 58271918 /api/reference/58271918 65. Arnold, D., Girling, A., Stevens, A., Lilford, R.: Comparison of direct and indirect methods of estimating health state utilities for resource allocation: Review and empirical analysis. BMJ (Clinical Res. ed). 339(b2688) (2009). https://doi.org/10.1136/bmj.b2688, DOI: 10.1136/bmj.b2688 65 10.1136/bmj.b2688 false true Reference 58271919 /api/reference/58271919 66. Cohen, J.: Statistical Power Analysis for the Behavioral Sciences. Academic (2013), DOI: 10.4324/9780203771587 66 10.4324/9780203771587 false true Reference 58271920 /api/reference/58271920 67. Tomczak, M., Tomczak, E.: The need to report effect size estimates revisited. An overview of some recommended measures of effect size. Tren Sport Sci. 21(1), 19–25. (2024) 67 false true Reference 58271921 /api/reference/58271921 68. Tamási, B., Brodszky, V., Péntek, M., et al.: Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus. Br. J. Dermatol. 180(4), 802–809 (2019). https://doi.org/10.1111/bjd.16883, DOI: 10.1111/bjd.16883 68 10.1111/bjd.16883 false true Reference 58271922 /api/reference/58271922 69. Rencz, F., Mukuria, C., Bató, A., Poór, A.K., Finch, A.P.: A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis. Quality of Life Research. 31(10), 3049–3060 (2022). https://doi.org/10.1007/s11136-022-03141-y, DOI: 10.1007/s11136-022-03141-y 69 10.1007/s11136-022-03141-y false true Reference 58271923 /api/reference/58271923 70. Swinburn, P., Lloyd, A., Boye, K.S., Edson-Heredia, E., Bowman, L., Janssen, B.: Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: Lessons learned from a feasibility study in the UK. Value Health. 16(8), 1156–1162 (2013). https://doi.org/10.1016/j.jval.2013.10.003, DOI: 10.1016/j.jval.2013.10.003 70 10.1016/j.jval.2013.10.003 false true Reference 58271924 /api/reference/58271924 71. Szlávicz, E., Szabó, Á., Kinyó, Á., et al.: Content validity of the EQ-5D-5L with skin irritation and self-confidence bolt-ons in patients with atopic dermatitis: A qualitative think-aloud study. Quality of Life Research. 33(1), 101–111 (2024). https://doi.org/10.1007/s11136-023-03519-6, DOI: 10.1007/s11136-023-03519-6 71 10.1007/s11136-023-03519-6 false true Reference 58271925 /api/reference/58271925 72. Hajdu, K., Brodszky, V., Stalmeier, P.F.M., et al.: Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus. J. Eur. Acad. Dermatology Venereology 33(11), 2106–2113 (2019). https://doi.org/10.1111/jdv.15765, DOI: 10.1111/jdv.15765 72 10.1111/jdv.15765 false true Reference 58271926 /api/reference/58271926 73. Jantarakolica T., Wanitphakdeedecha R., Yan C., et al: Willingness to Pay and Time Trade-off in Thai Patients with Port-Wine Stains. ClinicoEconomics and outcomes research. 14:635–642. (2022) https://doi.org/10.2147/ceor.S382735, DOI: 10.2147/ceor.S382735 73 10.2147/ceor.S382735 false true Reference 58271927 /api/reference/58271927 74. Küster, D., Haufe, E., Rethberg, C., Bauer, A., Seidler, A., Schmitt, J.: Health utilities for controlled and uncontrolled chronic hand eczema in healthcare employees. Contact Dermat. 78(1), 18–27 (2018). https://doi.org/10.1111/cod.12863, DOI: 10.1111/cod.12863 74 10.1111/cod.12863 false true Reference 58271928 /api/reference/58271928 75. Leeyaphan, C., Wanitphakdeedecha, R., Manuskiatti, W., Kulthanan, K.: Measuring melasma patients’ quality of life using willingness to pay and time trade-off methods in Thai population. BMC Dermatol. 11, 16 (2011). https://doi.org/10.1186/1471-5945-11-16, DOI: 10.1186/1471-5945-11-16 75 10.1186/1471-5945-11-16 false true Reference 58271929 /api/reference/58271929 76. Maymone, M.B.C., Rajanala, S., Widjajahakim, R., Secemsky, E., Saade, D., Vashi, N.A.: Willingness-to-pay and Time Trade-off: The Burden of Disease in patients with Benign Hyperpigmentation. J. Clin. Aesthetic Dermatol. 12(5), 46–48 (2019) 76 false true Reference 58271930 /api/reference/58271930 77. Poór, A.K., Brodszky, V., Péntek, M., et al.: Is the DLQI appropriate for medical decision-making in psoriasis patients? Arch. Dermatol. Res. 310(1), 47–55 (2018). https://doi.org/10.1007/s00403-017-1794-4, DOI: 10.1007/s00403-017-1794-4 77 10.1007/s00403-017-1794-4 false true Reference 58271931 /api/reference/58271931 78. Schmitt, J., Meurer, M., Klon, M., Frick, K.D.: Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: A population-based study. Br. J. Dermatol. 158(2), 351–359 (2008). https://doi.org/10.1111/j.1365-2133.2007.08354.x, DOI: 10.1111/j.1365-2133.2007.08354.x 78 10.1111/j.1365-2133.2007.08354.x false true Reference 58271932 /api/reference/58271932 79. Seidler, A.M., Bayoumi, A.M., Goldstein, M.K., Cruz, P.D. Jr., Chen, S.C.: Willingness to pay in dermatology: Assessment of the burden of skin diseases. J. Invest. Dermatol. 132(7), 1785–1790 (2012). https://doi.org/10.1038/jid.2012.50, DOI: 10.1038/jid.2012.50 79 10.1038/jid.2012.50 false true Reference 58271933 /api/reference/58271933 80. Lundberg, L., Johannesson, M., Silverdahl, M., Hermansson, C., Lindberg, M.: Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br. J. Dermatol. 141(6), 1067–1075 (1999). https://doi.org/10.1046/j.1365-2133.1999.03207.x, DOI: 10.1046/j.1365-2133.1999.03207.x 80 10.1046/j.1365-2133.1999.03207.x false true Reference 58271934 /api/reference/58271934 81. Schiffner, R., Brunnberg, S., Hohenleutner, U., Stolz, W., Landthaler, M.: Willingness to pay and time trade-off: Useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains. Br. J. Dermatol. 146(3), 440–447 (2002). https://doi.org/10.1046/j.1365-2133.2002.04613.x, DOI: 10.1046/j.1365-2133.2002.04613.x 81 10.1046/j.1365-2133.2002.04613.x false true Reference 58271935 /api/reference/58271935 82. Jiang, R., Shaw, J., Mühlbacher, A., et al.: Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off. Qual Life Res. 30(5), 1433–1444 (2021). https://doi.org/10.1007/s11136-020-02712-1, DOI: 10.1007/s11136-020-02712-1 82 10.1007/s11136-020-02712-1 false true Reference 58271936 /api/reference/58271936 83. Matza, L.S., Stewart, K.D., Lloyd, A.J., Rowen, D., Brazier, J.E.: Vignette-based utilities: Usefulness, limitations, and methodological recommendations. Value Health. 24(6), 812–821 (2021). https://doi.org/10.1016/j.jval.2020.12.017, DOI: 10.1016/j.jval.2020.12.017 83 10.1016/j.jval.2020.12.017 false true Reference 58271937 /api/reference/58271937 84. Devlin, N., Roudijk, B., Ludwig, K. (eds.): Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide. Springer (2022) ISBN: 978-3-030-89288-3, DOI: 10.1007/978-3-030-89289-0 84 10.1007/978-3-030-89289-0 false true Reference 58271938 /api/reference/58271938 85. Patel, A., Jafferany, M.: Multidisciplinary and holistic models of care for patients with dermatologic Disease and Psychosocial Comorbidity: A systematic review. JAMA Dermatology. 156(6), 686–694 (2020). https://doi.org/10.1001/jamadermatol.2020.0394, DOI: 10.1001/jamadermatol.2020.0394 85 10.1001/jamadermatol.2020.0394 false true Reference 58271939 /api/reference/58271939 86. Peasgood, T., Mukuria, C., Brazier, J., et al.: Developing a New Generic Health and Wellbeing measure: Psychometric survey results for the EQ-HWB. Value Health. 25(4), 525–533 (2022). https://doi.org/10.1016/j.jval.2021.11.1361, DOI: 10.1016/j.jval.2021.11.1361 86 10.1016/j.jval.2021.11.1361 false true Reference 58271940 /api/reference/58271940 87. Rencz, F., Janssen, M.F.: Testing the Psychometric properties of 9 bolt-ons for the EQ-5D-5L in a General Population Sample. Value Health. 27(7), 943–954 (2024). https://doi.org/10.1016/j.jval.2024.03.2195, DOI: 10.1016/j.jval.2024.03.2195 87 10.1016/j.jval.2024.03.2195 false true /api/publication/35425736 Szabó Ákos et al. Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases. (2025) EUROPEAN JOURNAL OF HEALTH ECONOMICS 1618-7598 1618-7601 26 4 627-639<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10075068"><a href="/gui2/?type=authors&mode=browse&sel=10075068" target="_blank">Szabó Ákos (<span class="authorship-author-name">Szabó Ákos</span> <span class="authorAux-mtmt"> Számviteli szakemberek jóllétje és transzferárazás</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="Budapesti Corvinus Egyetem">BCE</span>/<span title="Társadalom- és Politikatudományi Intézet">TPTI</span>/Egészségpolitika Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10020545"><a href="/gui2/?type=authors&mode=browse&sel=10020545" target="_blank">Brodszky Valentin (<span class="authorship-author-name">Brodszky Valentin</span> <span class="authorAux-mtmt"> health outcome research</span>) </a> </span> <span class="author-affil"><span title="Budapesti Corvinus Egyetem">BCE</span>/<span title="Társadalom- és Politikatudományi Intézet">TPTI</span>/Egészségpolitika Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10048079"><a href="/gui2/?type=authors&mode=browse&sel=10048079" target="_blank">Rencz Fanni ✉ (<span class="authorship-author-name">Rencz Fanni</span> <span class="authorAux-mtmt"> orvostudomány, health outcomes research</span>) </a> </span> <span class="author-affil"><span title="Budapesti Corvinus Egyetem">BCE</span>/<span title="Társadalom- és Politikatudományi Intézet">TPTI</span>/Egészségpolitika Tanszék; <span title="Semmelweis Egyetem">SE</span>/Doktori Iskola</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;35425736" target="_blank">Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases</a></div> <div> <span class="journal-title">EUROPEAN JOURNAL OF HEALTH ECONOMICS</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1618-7598">1618-7598</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1618-7601">1618-7601</a>)</span>: <span class="journal-volume">26</span> <span class="journal-issue">4</span> <span class="page"> pp 627-639 </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1007/s10198-024-01728-5" target="_blank" href="https://doi.org/10.1007/s10198-024-01728-5"> DOI </a> </span> <span class="id identifier oa_GREEN" title=" Green "> <a style="color:blue" title="10415" target="_blank" href="http://unipub.lib.uni-corvinus.hu/10415"> CorvinusKutatasok </a> </span> <span class="id identifier oa_GREEN" title=" Green "> <a style="color:blue" title="206557" target="_blank" href="https://real.mtak.hu/206557"> REAL </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001320987700001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001320987700001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85205246131" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85205246131"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="39340749" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39340749&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Economics, Econometrics and Finance (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Health Policy&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Gazdaságtudományi Doktori Minősítő Bizottság IXGJO GMB [1901-]&nbsp;&nbsp;&nbsp;B nemzetközi</div> <div class="journal-subject">Szociológiai Tudományos Bizottság IXGJO SZTB [1901-]&nbsp;&nbsp;&nbsp;B nemzetközi</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 8</span> | Független: 5 | Függő: 3 | Nem jelölt: 0 | WoS jelölt: 8 | Scopus jelölt:&nbsp;8 | WoS/Scopus jelölt:&nbsp;8 | DOI jelölt:&nbsp;8 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;35425736&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 20 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 35425736</span> | <span class="status-data status-ADMIN_APPROVED"> Admin láttamozott </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (Új Nemzeti Kiválóság Program (ÚNKP-22-3-II-SE-5)), (Bolyai János Kutatási Ösztöndíj (BO/00304/21)) Támogató: MTA Bolyai pályázat, ÚNKP-23-5-CORVINUS-5(Új Nemzeti Kiválóság Program) </div> <div class="notDuplums"><a target="_blank" href="/api/publication/35425736/notduplums">1 Nem duplumnak jelölés</a> </div> <div class="lastModified">Utolsó módosítás: 2026.06.02. 11:01 Boros Annamária (MTMT Központi admin) </div> <div class="lockedBy">Központi kezelésű 2026.06.05. 15:23 Boros Annamária (MTMT Központi admin) </div> </div></div>